UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
17.33
+0.49 (2.91%)
At close: Oct 8, 2025, 4:00 PM EDT
17.33
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:10 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $801.76 million as of October 8, 2025. Its market cap has increased by 40.61% in one year.
Market Cap
801.76M
Enterprise Value
762.55M
1-Year Change
40.61%
Ranking
Category
Stock Price
$17.33
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $801.76M, an increase of 340.77%. That is a compound annual growth rate of 19.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 779.10M | 73.36% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |